Cargando…

NSD1 supports cell growth and regulates autophagy in HPV-negative head and neck squamous cell carcinoma

Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer worldwide. Despite advances in therapeutic management and immunotherapy, the five-year survival rate for head and neck cancer remains at ~66% of all diagnosed cases. A better definition of drivers of HPV-negative HNSCC tha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Topchu, Iuliia, Bychkov, Igor, Gursel, Demirkan, Makhov, Petr, Boumber, Yanis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541623/ https://www.ncbi.nlm.nih.gov/pubmed/37786686 http://dx.doi.org/10.1101/2023.09.19.558537

Ejemplares similares

Regulation of VEGFR2 and AKT signaling by Musashi-2 in lung cancer
por: Bychkov, Igor, et al.
Publicado: (2023)

Regulation of VEGFR2 and AKT Signaling by Musashi-2 in Lung Cancer
por: Bychkov, Igor, et al.
Publicado: (2023)

Understanding the Roles of the NSD Protein Methyltransferases in Head and Neck Squamous Cell Carcinoma
por: Murali, Madhavi, et al.
Publicado: (2022)

Chromatin dysregulation associated with NSD1 mutation in head and neck squamous cell carcinoma
por: Farhangdoost, Nargess, et al.
Publicado: (2021)

The radiobiology of HPV-positive and HPV-negative head and neck squamous cell carcinoma
por: Zhou, Chumin, et al.
Publicado: (2020)

Musashi-2 (MSI2) regulates epidermal growth factor receptor (EGFR) expression and response to EGFR inhibitors in EGFR-mutated non-small cell lung cancer (NSCLC)
por: Makhov, Petr, et al.
Publicado: (2021)

NSD1 mutations by HPV status in head and neck cancer: differences in survival and response to DNA-damaging agents
por: Pan, Cassie, et al.
Publicado: (2019)

The Prognostic and Therapeutic Potential of DNA Damage Repair Pathway Alterations and Homologous Recombination Deficiency in Lung Cancer
por: Khaddour, Karam, et al.
Publicado: (2022)

Mechanisms of Cisplatin Resistance in HPV Negative Head and Neck Squamous Cell Carcinomas
por: Griso, Ana Belén, et al.
Publicado: (2022)

Radiosensitization approaches for HPV‐positive and HPV‐negative head and neck squamous carcinomas
por: Dok, Rüveyda, et al.
Publicado: (2019)

Radioimmunotherapy in HPV-Associated Head and Neck Squamous Cell Carcinoma
por: Zhou, Xin, et al.
Publicado: (2022)

Oncolytic activity of reovirus in HPV positive and negative head and neck squamous cell carcinoma
por: Cooper, Timothy, et al.
Publicado: (2015)

In vitro effects of gamma-secretase inhibition in HPV-positive and HPV-negative head and neck squamous cell carcinoma
por: Varatanovic, Sara, et al.
Publicado: (2023)

Advancements in the Management of HPV-Associated Head and Neck Squamous Cell Carcinoma
por: Zeitlin, Ross, et al.
Publicado: (2015)

HPV Detection in Head and Neck Squamous Cell Carcinomas: What Is the Issue?
por: Augustin, Jeremy Gbenakpon, et al.
Publicado: (2020)

The DNA Damage Response Is Differentially Involved in HPV-Positive and HPV-Negative Radioresistant Head and Neck Squamous Cell Carcinoma
por: Bamps, Marieke, et al.
Publicado: (2021)

Clinical applications of liquid biopsy in HPV-negative and HPV-positive head and neck squamous cell carcinoma: advances and challenges
por: Chantre-Justino, Mariana, et al.
Publicado: (2022)

Prognostic Score Predicts Survival in HPV-Negative Head and Neck Squamous Cell Cancer Patients
por: Qian, Xu, et al.
Publicado: (2019)

The convergent roles of NF-κB and ER stress in sunitinib-mediated expression of pro-tumorigenic cytokines and refractory phenotype in renal cell carcinoma
por: Makhov, Peter, et al.
Publicado: (2018)

Autophagy-Related Signature for Head and Neck Squamous Cell Carcinoma
por: Li, Cheng, et al.
Publicado: (2020)

Adaptive immune resistance in HPV-associated head and neck squamous cell carcinoma
por: Pai, Sara I.
Publicado: (2013)

Management of HPV-Related Squamous Cell Carcinoma of the Head and Neck: Pitfalls and Caveat
por: Perri, Francesco, et al.
Publicado: (2020)

An Immunocompetent Mouse Model of HPV16(+) Head and Neck Squamous Cell Carcinoma
por: Carper, Miranda B., et al.
Publicado: (2019)

PYHIN Proteins and HPV: Role in the Pathogenesis of Head and Neck Squamous Cell Carcinoma
por: Riva, Giuseppe, et al.
Publicado: (2019)

Therapeutic strategies of different HPV status in Head and Neck Squamous Cell Carcinoma
por: Sun, Yingming, et al.
Publicado: (2021)

Characteristics of B lymphocyte infiltration in HPV(+) head and neck squamous cell carcinoma
por: Zhang, Siwei, et al.
Publicado: (2021)

De-Escalating Strategies in HPV-Associated Head and Neck Squamous Cell Carcinoma
por: Economopoulou, Panagiota, et al.
Publicado: (2021)

Proteome and phosphoproteome signatures of recurrence for HPV(+) head and neck squamous cell carcinoma
por: Kaneko, Tomonori, et al.
Publicado: (2022)

Comprehensive analysis of mitophagy in HPV-related head and neck squamous cell carcinoma
por: Yanan, Li, et al.
Publicado: (2023)

A Pilot Study Comparing HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinomas by Whole Exome Sequencing
por: Nichols, Anthony C., et al.
Publicado: (2012)

Low expression of NSD1, NSD2, and NSD3 define a subset of human papillomavirus-positive oral squamous carcinomas with unfavorable prognosis
por: Gameiro, Steven F., et al.
Publicado: (2021)

Phospho-(T356)RB1 predicts survival in HPV-negative squamous cell carcinoma of the head and neck
por: Beck, Tim N., et al.
Publicado: (2015)

High enhancer activity is an epigenetic feature of HPV negative atypical head and neck squamous cell carcinoma
por: Callahan, S. Carson, et al.
Publicado: (2022)

Musashi 2 (MSI2) expression as an independent prognostic biomarker in non-small cell lung cancer (NSCLC)
por: Topchu, Iuliia, et al.
Publicado: (2021)

Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial
por: Ferris, Robert L, et al.
Publicado: (2021)

The Follicular Dendritic Cells and HPV 18 Interrelation in Head and Neck Squamous Cell Carcinomas of the Larynx
por: Boia, Eugen Radu, et al.
Publicado: (2023)

Induction of heparanase by HPV E6 oncogene in head and neck squamous cell carcinoma
por: Hirshoren, Nir, et al.
Publicado: (2014)

Identification and functional validation of HPV-mediated hypermethylation in head and neck squamous cell carcinoma
por: Lechner, Matthias, et al.
Publicado: (2013)

HPV, tumour metabolism and novel target identification in head and neck squamous cell carcinoma
por: Fleming, Jason C., et al.
Publicado: (2019)

Unique DNA methylation signature in HPV-positive head and neck squamous cell carcinomas
por: Degli Esposti, Davide, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_eaphkr0c00pnv8j6hm86bj447r